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Abstract  
Objective: This study examines the long-term effects of ingesting hydrolyzed beef protein 
versus carbohydrate on indirect markers of immunity during 10-week of endurance training 
in master-aged triathletes (n=16, age 35–60 years old).  
Methods: Participants were randomly assigned to either hydrolyzed beef protein (PRO, n=8) 
or non-protein isoenergetic carbohydrate (CHO, n=8) condition, which consisted of ingesting 
20 g of each supplement, mixed with water, once a day immediately post-workout, or before 
breakfast on non-training days. Salivary Human Neutrophil Peptides (HNP1-3) were 
measured before and after performing an incremental endurance test to volitional exhaustion 
at both pre and post intervention. Additionally, baseline levels of platelets, neutrophils, 
eosinophil basophils, monocytes, and lymphocytes were determined at pre and post 
intervention.  
Results: No significant changes in baseline concentration and secretion rate of salivary 
HNP1-3 were observed either treatment. The CHO group showed a non-significant decrease 
in resting HNP1-3 concentrations following the intervention (p=0.052, effect size d=0.53). 
Protein supplementation demonstrated a significant reduction in lymphocyte counts pre-to-
post intervention (mean [SD]: 2.30 [0.57] vs. 1.93 [0.45] 103/mm3, p=0.046, d=0.77) along 
with a moderate but not statistically significant increase (d=0.75, p=0.051) of the Neutrophil-
to-Lymphocyte ratio.  
Conclusions: In master-aged triathletes, post-workout ingestion of only protein, with no 
carbohydrate, may not be as effective as carbohydrate alone to attenuate negative long-term 
changes of some salivary and cellular immunological markers. Future studies should consider 
the co-ingestion of both macronutrients. 
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INTRODUCTION 
Multiple factors influence an athlete‘s resistance to illness inclusive of one’s genetic 
predisposition, immune competence, nutrition status, physical, psychological and 
environmental stresses and alterations in normal sleep schedule [1]. Athletes undertaking 
regular intensive and high-volume endurance exercise increase their susceptibility to upper 
respiratory tract infections (URTI) for up to two weeks following endurance events [2].  
Several strategies, including nutritional interventions have been proposed to maintain 
immunocompetence and to avoid illness [3, 4].   
Defensins, including alpha-defensins, are antimicrobial peptides (AMP) that 
contribute to the mucosal host defense acting as the first line of action against invading 
pathogens [5]. Salivary human neutrophil peptides (mainly HNP1-3) encompass a specific 
group of alpha-defensins that increases in response to the respiratory distress syndrome [6]. 
However, their response to an acute or chronic exercise stimulus is still unclear. Acute 
increases in the concentration of HNP1–3 and other AMP (i.e. LL-37, LL-37, L Lactoferrin, 
and Lysozyme) have been reported after 2.5 h [7, 8] or 45 minutes [9] of submaximal (60% 
to 75% of V̇O2peak) endurance exercises.  Conversely, decreases in basal levels and secretion 
rates of HNP1-3 were also observed after an 8-week resistance-training program in young 
males who regularly consumed a post-workout beverage containing hydrolyzed beef proteins 
and carbohydrates [10]. As lower basal levels of HNP1-3 have been associated with reduced 
risks against virus and infections [11], along with higher performance productions [6], the 
decreased concentrations in athletes have been connected with a better capacity to overcome 
the degree of stress determined by a given exercise protocol [10]. 
While the ingestion of carbohydrates during and after heavy exercises to counteract 
the exercise-induced immune dysfunction is a consistent recommendation [3], the potential 
benefits of nutrients containing high concentration of essential amino acids and 
micronutrients need to be established [12, 13]. Due to the critical role of vitamins, minerals 
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and sulphur-containing amino acids (e.g. cysteine and taurine) in supporting anti-oxidant, 
muscle recovery and immune responses [12], the effect of special food preparations 
providing high-quality proteins, fats and elevated proportion of micronutrients (e.g. heme-
iron, zinc and vitamin B12,) on acute and long term immunity in athletes requires further 
investigation. Additionally, as the ingestion of carbohydrates has been proven to attenuate 
the exercise-induced immunosuppression in endurance athletes [2, 3], the purpose of this 
study was to compare the long-term induced immunological effects of ingesting a 
commercially-available post-workout hydrolyzed beef protein (100% All Beef, Crown® 
Sport Nutrition, Spain) vs. a non-protein, isoenergetic carbohydrate-only supplement on 
indirect markers of humoral and cellular immunity in recreationally trained master-age 
endurance athletes.  
The primary outcome was resting/basal HNP1-3 concentration and secretion rate 
measured after completing a 10-week intervention period. Secondary outcomes included 
changes in HNP1-3 induced by an incremental test to volitional exhaustion, leukocyte count 
and the Neutrophil-to-Lymphocyte ratio, as the latter has been associated with performance 
fluctuations and immune system related changes in athletes [1]. We hypothesize that the 
regular ingestion of a post-workout beef protein drink will attenuate changes associated with 
the immune dysfunction in a similar way to the ingestion of carbohydrates.  
MATERIALS AND METHODS 
Participants 
Twenty-four recreationally master-age male triathletes, not involved in regular 
official federative competitions, met the requirements to participate in this study. Inclusion 
criteria included: (a) being 35–60 years of age, (b) participating in regular endurance training 
history for at least two years with a minimum of 3 sessions and 6 h of endurance training 
exposure per week (c) having a normal health history, (d) being free from musculoskeletal 
limitations, (e) agreeing not to ingest any other nutritional supplements or non-prescription 
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drugs/medication that can affect blood markers of health as well as muscle growth and the 
ability to train intensely during the study, and (f) fluent in English in order to receive 
instructions regarding the study. Participants were excluded if they presented with: (a) a 
history of metabolic conditions and/or diseases, (b) use of a variety of medications including, 
but not limited to, those with androgenic and/or anabolic effects and/or nutritional 
supplements known to improve strength and/or muscle mass such as creatine, essential amino 
acid, whey protein, glutamine, dehydroepiandrosterone (DHEA), multi-vitamin or iron-
supplement within 8 weeks prior to the start of the study, (c) current use of tobacco products, 
and (d) the presence of any soft tissue or orthopedic limitations. 
Participants were informed of the potential risks of the intervention before agreeing 
to comply with the intervention protocol and signed an informed consent. All experimental 
procedures were conducted in accordance with the Declaration of Helsinki and approved by 
the University Research Ethics Committee. After determining eligibility, 24 participants 
were recruited for the study. Due to reasons not related to the intervention protocols, 8 
participants withdrew from the study (Figure 1). Consequently, sixteen participants (n = 8 
per treatment) successfully completed the intervention. The study was conducted during the 
winter and spring period. Trial Registration: ClinicalTrials.gov, U.S. National Institutes of 
Health (Identifier: NCT02675348).  
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Figure 1. Flow diagram of participants throughout the course of the study 
 
Experimental design  
This study was a randomized, parallel group controlled trial employing a double blind 
between-participant design. Participants were randomly allocated into two treatment groups: 
beef protein (PRO, n = 8) or maltodextrin (CHO, n = 8). The primary outcome was 
resting/basal HNP1-3 concentration and secretion rate. Secondary outcomes included the 
following: (i) changes in HNP1-3 measured after performing the incremental test to volitional 
exhaustion in order to examine the acute response to exercise, (ii) leukocyte count (iii), the 
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♦	Excluded from analysis (n=0)	
Lost to follow-up (n=4) 
Discontinued intervention  (n=4) 
Follow-Up	
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Neutrophil-to-Lymphocyte ratio, (iv) peak oxygen uptake (V̇O2peak), and (v) total white blood 
cells, involving granulocytes (neutrophils, eosinophil, and basophils) and agranulocytes 
(monocytes and lymphocytes). All tests were performed at baseline and follow-up. To assess 
the long-term effect on the basal levels and the exercise-induced changes in concentration 
and secretion rates of salivary HNP1-3, saliva samples were collected four times, pre and 
post an incremental laboratory exercise test to volitional exhaustion performed before (test 
1) and after (test 2) the 10-week intervention period. Following a pre-intervention screening, 
the participants were matched for V̇O2peak and age, and then assigned to their respective 
treatments by block randomization, using a block size of two, generated by a computer tool.  
Measurements 
 Anthropometry and V̇O2peak: Body mass and height were assessed on a standard scale 
and stadiometer according to the methods described by Ross and Marfel-Jones [14]. Peak 
oxygen consumption was examined after a standardized warm-up where participants 
completed an incremental laboratory exercise test to volitional exhaustion on a Cyclus2 
ergometer (RBM Electronics, Leipzig, Germany). The test commenced at a work rate of 90 
W. Thereafter, intensity increased at a rate of 25 W min−1. Participants were instructed to 
maintain a cadence between 70 and 80 rev min-1 throughout the test. When cadence dropped 
by more than 10 rev min−1 for more than 10 s despite strong verbal encouragement, tests were 
terminated. Expired gases were collected continuously during the test using a Cortex 
MetaLyzer 3B gas analyzer (Cortex Biophysik, Leipzig, Germany). Heart rate (HR) was 
continuously monitored using a Polar Sport Tester™ (Polar Electro, Finland). We calculated 
V̇O2peak as the highest mean oxygen consumption over a 30-s period [15]. This incremental 
test was chosen because it was the only standardized assessment protocol routinely 
performed for the participants that volunteered to take part in the study. Furthermore, similar 
protocols have been recommended to objectively determine physiological performance and 
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quantify relative work intensity based on laboratory-derived parameters associated with 
maximal exercise testing [16, 17]. 
Blood Sampling and Analysis: On two separate occasions (one day before and one 
day after completing the 10-week intervention period), participants arrived at the physiology 
laboratory after fasting for 8 h and with a minimum rest period of 24 h from the last exercises 
session. Two vacutainer venous blood collection tubes (BD Vacutainer® Blood Collection 
Tubes) were used to collect 8 mL of venous blood from the antecubital vein. An aliquot of 
the whole blood was used to perform leukocyte (Total, Neutrophils, Lymphocytes, 
Monocytes, Eosinophil and Basophils) counts and the Neutrophils-to-Lymphocyte ratio, as 
general markers of cell immunity using an automated hematology analyzer (ABX Pentra 
60C+, Horiba Medical, Montpellier, France).  
Saliva Collection: Saliva was collected before (test 1) and after (test 2) the 10-week 
intervention period before and after the incremental V̇O2peak test, four times in total. At 
baseline (pre test), saliva samples were collected following the blood samples just a few 
minutes before starting the assessment. For the post-test sample, saliva was collected 60 min 
after the exercise cessation [9]. Participants remained seated for 10 min (pre test) or about 60 
min (post test) prior to each saliva collection. No fluid or food was permitted until after the 
final 1-hour post-exercise saliva sample had been collected. For all saliva samples, the mouth 
was rinsed with water 5 min before collection. The participant was requested to swallow in 
order to empty the mouth before each sample collection. Unstimulated whole saliva was 
collected by the spitting method while the participant remained seated, leaning forward and 
with the head tilted down [18]. Saliva was collected for 1 min. To avoid circadian variation, 
saliva samples were collected between 2-7 pm. The collected saliva was weighed in order to 
obtain precise flow rate (g/min) [19]. The saliva was stored at -80°C until further sample 
treatment and analysis. 
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Saliva analysis: Saliva samples were centrifuged (12,000 g, 10 min 4° C) and the 
supernatant diluted 1000x with sample dilution buffer. Each sample was analyzed in 
duplicate with ELISA (Hycult biotech, Netherlands) following the manufacturer’s 
instructions. The calibration curve consisted of eight standards, ranging from 0.15 to 10 
μg/mL HNP1-3. Absorbance (450 nm) values for the saliva samples were interpolated from 
calibration standards with a 4-parameter logistic curve (My assays, version 2015). In 
addition, the alpha-defensins HNP1-3 secretion rates were determined by multiplying their 
concentration by the flow rate (mL min−1). 
Dietary Monitoring  
Each participant’s baseline diet (3 days, 2 weekdays, and 1 weekend day) was 
analyzed using Dietplan 6 software (Microsoft Forestfield Software Ltd. 14). Participants 
were instructed to maintain their normal diet throughout the intervention. In order to evaluate 
differences caused by the supplementation protocol, diet was analyzed again during the last 
week of the intervention. 
Control of Training 
The participants were master triathletes and at the time of the study had consistently 
trained between 6-10 h per week (four to seven weekly training sessions) for the past three 
years. Heart rate (HR), Rate of Perceived Exertion (RPE) using a 15-point, 6 to 20 Borg scale 
[20], oxygen consumption, and the identification of the first (VT1) and second (VT2) 
ventilatory thresholds were recorded during the testing procedures. Following the pre-
screening tests, participants committed to follow a training intervention period consisting of 
a 10-week polarized endurance-training intensity distribution model including three intensity 
zones based on the VT1 and VT2 localization [21]. HR and the associated RPE values 
assessed during the incremental test were used to quantify the training performed within each 
intensity zone. The polarized endurance-training intensity distribution model involves 
signiﬁcant proportions of both high- and low-intensity training and only a small proportion 
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of moderate-intensity training [22]. The intensity zones were calculated as Zone 1, low 
intensity: ≤ 75% of VT2 or below the VT1, ≤ 72% of maximum heart rate (HRmax), rate of 
perceived exertion (RPE) 6 to 11; Zone 2, moderate intensity: above VT1, between 76 and 
95% of VT2, 73 to 82% HRmax, RPE 12 to 14; and Zone 3, high intensity: between 96 and 
120% of VT2, 83 to 97% HRmax, RPE 15 to 18 [21]. Participants trained 6 sessions per week 
with a distribution of 75–80% in Zone 1, ~5% in Zone 2, and 15–20% in Zone 3. The weekly 
training program included three bouts of running, involving an average of 25 to 30 km, two 
bouts of swimming involving an average of 2 km, and three bouts of cycling involving an 
average of 55 km. HR and RPE data files were checked weekly and used to quantify training 
intensity. In addition, participants were required to complete a training diary, recording 
average HR, training mode, and duration and distance of training sessions throughout the 
study. Continuous monitoring of the training load was conducted using two methods: (i) 
Strava [23] and (ii) face-to-face/telephone interviews after every session. These procedures 
allowed us to maintain permanent contact with all the participants and adjust the training 
configuration to ensure similar training load in both groups. The adjustments in training 
intensity during the intervention period were determined through RPE and HR. All the 
participants performed their training during the afternoon (12:00 to 6:00 pm).  
Dietary Supplementation and Control of the Intervention Compliance 
 The two supplements under investigation were presented as 20 g sachets of vanilla-
flavored powder diluted in ~300 mL of plain water for each intake. The diluted drinks were 
similar in appearance, texture and taste, and were isoenergetic. The nutritional composition 
of each product and the amino acid profile of the hydrolyzed beef proteins are shown in Table 
1. Supplements were taken once a day during 10 weeks for a cumulative total of 70 doses. 
On training days, supplements were ingested just after the training, whereas on non-training 
days supplements were self-administered in the morning before breakfast.  
Table 1  
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After completing the first assessment session, each participant was given a batch of 
one of the two products, assigned according to randomization. Tolerance, collected from any 
adverse events and compliance with supplement intake (determined by an individual follow-
up), was evaluated continuously during the intervention. Only participants who completed 
the 70 days of supplementation intake with a minimum training frequency of 4 sessions per 
week (40 workouts in total) were included in the analysis. 
Statistical Analysis 
Sample size estimations were calculated based on antimicrobial markers (Alpha- 
defensins HNP1-3 concentration and secretion rates), assuming a two group by four repeated 
measures model, where 0.05 was chosen as α-error probability and 0.80 was chosen for 
statistical power (1-β). A descriptive analysis was performed, and the Kolmogorov-Smirnov 
and Shapiro-Wilk’s tests were applied to assess normality. Sample characteristics at baseline 
were compared between conditions (PRO vs. CHO) using two-tailed independent means 
Student’s t test. Changes pre to post treatment in the baseline levels of the salivary markers, 
V̇O2peak and leukocytes were assessed using a 2 (treatments) × 2 (times) repeated measures 
ANOVA. As suggested by Castañeda et al., changes in the primary outcome (e.g., HNP1-3 
concentration and secretion rate) from pre intervention baseline (pre-exercise/resting test 1) 
to post intervention baseline (pre-exercise/resting pre test 2) were analyzed using a priori 
Bonferroni-adjusted pairwise comparisons [24]. Additionally, as changes in the 
concentration and secretion rate of the HNP1-3 after the incremental test would be also 
dependent on each individual’s baseline value [7], one-way Analysis of Covariance 
(ANCOVA) models were used to compare differences in raw change between groups, using 
the pre-assessment values as covariates. Confidence intervals (CI) of the adjusted differences 
were calculated and plotted. Those CIs not crossing zero were considered statistically 
significant. Additionally, two-tailed one sample student’s tests were used to test for a null 
hypothesis. Generalized eta squared (𝜂𝜂%
& ) and Cohen’s d values were reported to provide an 
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estimate of standardized effect size (small d=0.2, 𝜂𝜂%
&=0.01; moderate d=0.5, 𝜂𝜂%
&=0.06; and 
large d=0.8, 𝜂𝜂%
&=0.14 values were used as reference) [25]. Significance level was set to 
p<0.05, but p values between 0.05 and 0.1 were considered indicative of a trend [26]. Data 
are presented as Mean (SD) and mean change (95% confidence intervals) unless otherwise 
noted. All statistics were performed using the Statistical Package for the Social Sciences 
(IBM statistics, version 20.0.0.1. for Windows). 
RESULTS  
The statistical power of the study was assessed by performing correlations among 
repeated measures (pre to post) of the salivary alfa defensins HNP1-3 and leukocytes. Results 
ranged from r=0.63 to r=0.74. Assuming the most conservative value, significance level 0.50 
and power 0.80, the sample size was determined to be large enough to detect moderate group-
time interactions effects (𝜂𝜂%
&=0.09) through a sensitivity power analysis. 
The baseline characteristics for each group were as follows: PRO, age 48 (8) years, 
height 1.76 (0.07) m, body mass 78.50 (8.48) kg, V̇O2peak 43.25 (4.97) ml/kg/min-1. CHO, age 
46 (6.89) years, height 1.80 (0.04) m, body mass 78.62 (5.22) kg V̇O2peak 42.88 (4.31) 
ml/kg/min-1. No significant differences were observed between treatments at baseline. 
Participants confirmed that they maintained their regular diet throughout the trial period. 
Table 2 shows the average daily dietary characteristics for carbohydrate, protein, fat (g.kg-
1.d-1), and energy (kcal.kg-1.d-1) consumption before and after intervention for the two 
treatment groups. At baseline, no between-group differences were observed for the amount 
of the macronutrients or energy intake. However, during the course of the nutritional 
intervention, protein and carbohydrate consumption increased relative to the two respective 
treatments. No other differences in diet were noted.  
Table 2 
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All the participants reported the completed training diary at the end of the 
intervention. Training load quantification demonstrated the following training load (volume 
and intensity) distribution for all the participants included in the final analysis:  
(i) total volume (km) completed during the 10-week intervention period in zone 1, 2 
and 3 respectively PRO: 671 (3.1), 50 (2.8), 124 (6.5). CHO: 659 (3.9) 56 (2.9), 136.5 (5.6). 
no significant differences were observed between treatment for each of the three intensity 
zones (p>0.05).  
(ii)  The training-time distribution was as follows: (i) (ii) 73 (2.1) % - 7 (0.3)% - 20 
(1.0) % for Zone 1; Zone 2 and Zone 3 respectively.  
Primary Outcome: Salivary alpha-defensins HNP1-3  
No main time or treatment effects were observed for the HNP1-3 concentrations 
(Time: F[1,14]=0.83, p=0.377,	𝜂𝜂%
&=0.01; Treatment F[1,14]=0.04, p=0.850, 	𝜂𝜂%
&= 0.01) or 
saliva flow rates (Time: F[1,14]=0.00, p=0.953, 𝜂𝜂%
&=0.01; Treatment: F[1,14]=0.25, p=0.625, 
𝜂𝜂%
&=0.03). Furthermore, no interaction effects between treatments and time for HNP1-3 
concentrations (F[1,44]=4.38, p=0.055, 𝜂𝜂%
&=0.06) and secretion rate  (F[1,14]=1.82, p=0.198, 
𝜂𝜂%
&=0.04) were found. To have a closer look at the interaction effect observed for the HNP1-
3 concentration, post hoc analysis revealed a trend (p=0.052, d=0.53) to decrease the 
concentration of salivary alpha-defensins HNP1-3 in the CHO group at post intervention (pre 
test 2 vs. pre test 1), Figure 2.  
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Figure 2. Long-term changes in the concentration (A) and secretion rates (B) of 
salivaryalpha-defensins HNP1-3 for the two treatment conditions (mean and SEM). 
T, p=0.055 for the CHO at pre test 2 (post intervention) vs. pre test 1 (pre intervention) 
 
The adjusted covariate model revealed a significant decrease of the HNP1-3 salivary 
flow rate for both treatment conditions PRO, (p=0.039, d=0.55) and CHO (p=0.030, d=0.58). 
Furthermore, the PRO condition showed a moderate effect size (p=0.052, d=0.51) to decrease 
the concentration of HNP1-3 after performing the incremental test at post intervention respect 
to the values measured at baseline pre intervention (Figure 3). 
 
Figure 3. Estimated marginal means and 95% confidence intervals of changes in the 
concentration (A) and secretion rate of the salivary alpha-defensins HNP1-3. Analysis of 
covariance (ANCOVA) models were used to compare differences in raw change between 
groups, using the pre-assessment values as covariates. T, p = 0.052; *, p < 0.05 from the 
baseline values. 
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Secondary Outcomes: V̇O2peak and white blood cell  
No differences in V̇O2peak or white blood cell counts were observed at baseline. Pre 
and post values of V̇O2peak and Leukocytes counts, main time and group effects, as well as 
interactions between treatments and time, are provided in Table 3. Only the PRO treatment 
showed a statistically significant main time effect on Lymphocytes. Post hoc analysis 
revealed a significant decrease in Lymphocytes (p=0.046, d=0.77) and a very close to 
significant p-value with a moderate effect size (p=0.051, d=0.75) to increase Neutrophil-to-
Lymphocyte ratio in the PRO condition. Furthermore, a moderate effect size (d=0.60) with 
no statistically significant rise (p=0.112) in Neutrophil count was also observed in PRO. No 
other differences were observed. 
Table 3 
DISCUSSION 
The main finding of the present investigation is that the ingestion of a post-workout 
drink providing only protein (from beef) or carbohydrate from maltodextrin during 10 weeks 
of endurance training was not associated with significant changes in the basal concentration 
and secretion rate of salivary HNP1-3. Nonetheless, ingesting carbohydrates for 10 weeks, 
produced a moderate effect size (d=0.53) to reduce the HNP1-3 (Figure 2A) and helped to 
attenuate the exercise-induced depression of this marker after the incremental test (Figure 
3A). Even though both groups decreased the HNP1-3 secretion rate measured after 
performing the incremental test post intervention (Figure 3B), only the PRO group exhibited 
a likely higher depression of the HNP1-3 concentration after the incremental test measured 
at post intervention (Figure 3A). In addition, a decrease in post-intervention lymphocyte 
count and a moderate to high effect size to increase the Neutrophil-to-Lymphocyte ratio was 
also observed for the participants allocated in the PRO group. Conversely, those participants 
who ingested a beverage containing only maltodextrin demonstrated no significant changes 
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in the analyzed cellular markers of immunity. Based on these findings, and within the 
confines of the study procedures, we reject our research hypothesis that the regular ingestion 
of a post-workout supplement providing only beef protein concordant to endurance training 
will attenuate negative changes of some components associated with immune dysfunction in 
a similar way to the ingestion of carbohydrates in master triathletes. 
Although an initial reduction in baseline concentration of some salivary AMP may be 
an adaptive, chronic outcome to endurance training [27], according to the present results, 
further decreases would be elicited by the ingestion of a post-workout carbohydrate beverage 
in trained athletes. Considering that HNP1-3 represents the combined response of three 
peptides (HNP1, HNP2 and HNP3), which are markers associated with exercise stress [6], 
showing low levels of these markers after a 10-week intervention period would be interpreted 
as a positive adaption that would allow individuals to better tolerate the stress imposed by a 
given exercise protocol. This rationale would support the hypothesis that the chronically 
reduced HNP1-3 level observed in trained athletes is an expected adaptations to endurance 
training [10], which in the present study is observed in the participants allocate in the CHO 
group.  
The analysis of the longitudinal individual changes between baseline values measured 
before performing test 1 (pre-intervention) and test 2 (post-intervention) revealed that six 
participants in the CHO group depicted a consistent decrease in their levels of HNP1-3, while 
one showed an increase and the other one produced almost no change. Conversely, the 
participants allocated to the PRO group showed a different pattern of response with two 
individuals showing a consistent decrease, four an increase, and two producing no change in 
the concentration of HNP1-3 at post intervention (see supplementary material). Similarly, 
Naclerio et al [10], reported a similar post intervention decrease of HNP1-3 levels in young 
resistance trained participants that ingested a post-workout beverage containing hydrolyzed 
beef protein and carbohydrates, for eight weeks. Despite the differences in the exercise 
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protocol and the characteristics of the participants, it could be speculated that the ingestion 
of admixtures including carbohydrates and high-quality animal-based proteins such as beef 
would represent a suitable immune protective nutritional countermeasure for athletes. Indeed, 
the ineffectiveness of the PRO treatment to attenuate the observed non-desired changes in 
some markers of immunity could be associated with the non-ingestion of carbohydrate, being 
proteins still considered a synergic nutrient to optimize training adaptations including, 
performance, muscle repair, and remodeling, etc. [28]. As the objective of the present study 
was to compare the effect of protein vs. carbohydrate alone, the inclusion of a group 
consuming a carbohydrate protein mixture was not considered.  
Although not significantly different at the beginning of the study, compared to the 
PRO condition, the CHO group consumed a lower amount of daily carbohydrates from their 
diet (2.98±1.18 g.kg-1.d-1 vs. 3.21±1.19 g.kg-1.d-1 respectively). However, the significant rise 
in total daily carbohydrates experienced by the CHO group during the intervention, increased 
the daily carbohydrate intake to a similar level as determined in the PRO group [3.23 (1.19) 
g.kg-1.d-1 and 3.46 (1.14) g.kg-1.d-1 for CHO and PRO respectively]. Consequently, the overall 
more favorable immune response observed in the CHO cohort could be mainly caused by the 
addition of a post workout CHO supplement. On the other hand, individual responses to 
training may explain the dissimilar results observed between participants allocated to the 
PRO condition and the opposite changes showed by one of the CHO consumers who tended 
to increase their levels of HNP1-3 at post intervention. 
The decreased after-intervention lymphocyte levels along with observed moderate 
effect size for increasing neutrophils and the concomitant rise in Neutrophils-to-
Lymphocytes ratio for the PRO condition together with the absence of changes in cellular 
immune markers in the CHO group would reinforce the aforementioned statement that 
carbohydrates would be an effective nutrient to effectively counteract exercise-induced 
cellular immune dysfunction in endurance athletes [3, 29]. Nonetheless, as previously 
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discussed, both groups consumed a similar amount of total daily carbohydrates during the 
intervention. Consequently, the regular ingestion of 20 g (0.20 to 0.29 g.kg-1.d-1kg) of 
maltodextrin administered as a post-workout supplement or in the morning during the non-
training days would represent an appropriate immune-protective nutritional strategy in 
master endurance athletes.  
Contrary to our results, previous studies reported acute increases in the concentration 
of HNP1-3 determined immediately after submaximal constant intensity long duration 
protocols [7, 9] or until 1 h compared to pre-exercise values [9]. The post exercise increase 
in salivary HNP1-3 levels may, to the same extent, be related to an exercise-induced muscle 
inflammatory response. Prolonged (> 45 min) dynamic exercise may induce airway 
inflammation and damage to airway epithelial cell. The aforementioned mechanism will 
activate neutrophils and elicit the release of their contents into saliva resulting in a rise of 
salivary levels of AMP after such as a type of exercise [30]. Even though the endurance 
exercise test was performed until volitional exhaustion, the characteristics of the incremental 
protocol used, starting at very low intensities (< VT1) to progressively reach the high 
intensity exercises zones (> VT2) where the participants only exercised for 4 to 7 minutes 
would not be enough to cause an acute meaningful rise in the post exercise salivary AMP. 
Indeed, the transient exercise-induced immune-depression has been mainly associated with 
low to moderate intensity and long continuous [1] or intermittent [13, 31] exercise but not 
with a singular, 12 to 18 min, incremental to volitional exhaustion protocol as performed in 
the present study. Only Allgrove et al. [32] reported a temporary increase in the secretion rate 
of both salivary immunoglobulin A and salivary lysozyme with no effect on saliva flow rate 
after a short-duration (~ 22 min) incremental exercise test to exhaustion in active young men. 
In this way, the observed responses could also be associated with the cohort’s characteristics. 
Participants in the present investigation were master-age triathletes, while previous studies 
have analyzed the acute response of young recreationally active participants [7, 9]. 
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Additionally, both conditions (PRO and CHO) showed almost the same concentration of 
HNP1-3 after performing the endurance test at post intervention (see supplementary 
material). Consequently, the trend to decrease HNP1-3 levels within our study for the PRO 
group may not be related to a higher post-exercise immunosuppression observed at the end 
of intervention but a consequence of the individual variability of the HNP1-3 concentration 
as reported by others [7], who have recognized the variance as a limitation for the detection 
of intervention-induced changes in mucosal parameters, particularly in parallel groups 
designs [33]. When individual responses were compared, it is worth noting that at test 1 
(before intervention) a mixed pattern of responses with 8 participants increasing and 8 
decreasing the concentration of HNP1-3 measured post exercise was observed (See 
supplementary material). After the 10-week intervention, all participants but one, who 
produced almost no change, allocated in the PRO group decreased the level of salivary 
HNP1-3 after exercise. On the other hand, participants in the CHO group showed a very 
similar, although more attenuated, pattern of response compared to the previously observed 
at test 1, with two participants increasing, 2 decreasing and 4 showing no change in the 
concentration of HNP1-3. Likely the absence of carbohydrates, administered alone or added 
to the post-workout protein beverage, could be influencing the observed trend to acutely 
reduce the concentration of salivary HNP1-3 after exercise. Nonetheless, participants in the 
CHO treatment attenuated changes in HNP1-3 concentrations at test 2. 
The unexpected after-intervention fall in salivary flow rate exhibited by the two 
treatment groups could be explained by the limited access to water [34] during the first hour 
post exercise that was implemented during the 10-week intervention period for all the 
participants. Even though testing conditions were replicated at pre and post intervention, the 
regular ingestion of only 300 ml solution providing ~7% of proteins or carbohydrate with 
limited access to water could have caused an adaptive response to a transitory limited post 
exercise re-hydration, which resulted in a reduced saliva flow during the first hour post 
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exercise. 
 Our study is not without limitations. Given the observed different patterns of AMP 
secretion between men and women [30], studies using female population would be needed. 
Nonetheless, a recent investigation examining a mixed sample of young resistance trained 
males and females observed no influence of sex on levels of salivary HNP1-3 measured 
before and after 8 weeks of a combined exercise and nutrition protocol [10]. Dehydration has 
been shown to decrease saliva flow rate secretion of AMP without affecting its concentrations 
[6]. Thus, maintaining hydration should be considered to preserve mucosal immune integrity 
during heavy endurance exercise. Unfortunately, while participants were asked to hydrate 
prior to each training and testing sessions, hydration status was not assessed. Although the 
used incremental to exhaustion test is useful for identifying changes in the V̇o2peak and 
designing endurance training zones in endurance athletes [17], a specific protocol reflecting 
triathlete performance during competitions would be useful to assess how the conducted 
intervention impact on their performance. The current study examined singular nutrients; 
thus, future research should consider mixed supplementation combining carbohydrate, 
protein, fats and micronutrients. Finally, further research using a larger sample size is 
required to confirm if nutritional interventions through a post workout animal protein drink 
administered alone or combined with carbohydrate can attenuate negative changes in immune 
markers in a similar way as carbohydrates do.  
In conclusion, considering the research design and sample size limitations this 
investigation suggests that a post-workout drink containing only protein with no 
carbohydrate, may not be as effective as the ingestion of carbohydrate alone to attenuate 
negative long-term changes on some salivary and cellular markers associated with immune 
dysfunction in master-aged triathletes. Nonetheless, given the demonstrated positive effect 
of post-workout protein supplementation to optimize recovery process, including muscle 
repair and glycogen replenishment in endurance athletes [28], the use of admixture 
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combining both high quality protein extract and carbohydrate deserves special 
considerations. 
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Tables 
Table 1.   
Nutritional composition of drinks per intake (20 g of powder plus ~300 ml of plain water) 
 Nutrient  PRO CHO  
Energy value (kcal) 82 82  
Carbohydrates (maltodextrin g) 0 20  
Lipids (g) 1.54 0  
Proteins (g) 16.40 0  
Alanine  1.04 -  
Arginine  1.06 -  
Aspartic acid 1.50 -  
Cysteine 0.16 -  
Glutamic acid  2.58 -  
Glycine  1.07 -  
Histidine 0.55 -  
Isoleucine 0.75 -  
Leucine  1.32 -  
Lysine  1.44 -  
Methionine 0.39 -  
Phenylalanine 0.65 -  
Proline  0.81 -  
Serine  0.65 -  
Threonine 0.73 -  
Tryptophan 0.187 -  
Tyrosine  0.52 -  
Valine  0.80 -  
Total EEA 6.82 -  
Heme Iron (mg) 3.25 -  
Zinc (mg) 3.81 -  
Potassium (mg)  241.96 -  
Phosphorus (mg)  154.67 -  
Selenium (µg) 4.86 -  
Folic Acid (µg) 16.84 -  
Vitamin B 12 (µg) 0.625  -  
Notes: EEA, essential amino acids; CHO, Carbohydrates.
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Table 2. Descriptive analysis of the participants’ diet composition 
Treatment 
PRO (n=8) CHO (n=8) 
pre post pre post 
Proteins 
(g.kg-1.d-1) 
1.29 
(0.25) 
1.52* 
(0.24) 
1.35 
(0.24) 
1.40 
(0.25) 
Carbohydrates 
(g.kg-1.d-1) 
3.36 
(1.21) 
3.46 
(1.14) 
2.98 
(1.18) 
3.23* 
(1.19) 
Fat 
(g.kg-1.d-1) 
1.07 
(0.26) 
1.09 
(0.26) 
1.37 
(0.80) 
1.34 
(0.60) 
Energy (kcal.kg-
1.d-1) 
28.58 
(4.40) 
30.54 
(4.17) 
27.94 
(7.97) 
31.44 
(9.28) 
Notes: Pre and post intervention values are presented as mean (SD). The diet analysis 
includes the amount of macronutrients added by the supplements (beef protein or 
maltodextrin). 
*p<0.01 from pre to post-intervention (last week of intervention)  
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Table 3. Descriptive analysis of the performance and blood immunological variables 
Variables 
PRO (n=8) CHO (n=8) Repeated Measure ANOVA 
(2 groups x 2 times) Pre Post Pre Post 
V̇O2peak (ml/kg/min) 
48.9  
(5.2) 
48.4 
(5.1) 
49.1 
(5.2) 
49.2 
(5.9) 
Time: F(1,14)=0.233, p=0.637, 𝜂𝜂%
&=0.01 
Group: F(1,14)=0.03, p=0.856, η)
&=0.01 
Group x Time: F(1,14)=0.476, p=0.856, η)
&=0.01 
Platelets  
(103/mm3) 
247.38  
(56.84) 
231.38 
(34.17) 
245.00 
(48.41) 
243.13 
(38.81) 
Time: F(1,14)=0.93, p=0.351, η)
&=0.01 
Group: F(1,14)=0.04, p=0.837, η)
&=0.01 
Group x Time: F(1,14)=0.58, p=0.459, η)
&=0.01 
Total Leukocytes  
(103/mm3) 
5.25  
(1.04) 
5.33 
(1.02) 
5.39 
(0.92) 
5.51 
(1.04) 
Time: F(1,14)=0.18, p=0.676, η)
&=0.01 
Group: F(1,14)=0.11, p=0.742, η)
&=0.01 
Group x Time: F(1,14)=0.01, p=0.917, η)
&=0.01 
Neutrophils  
(103/mm3) 
2.37  
(0.77) 
2.86  
(0.74) 
2.98 
(0.91) 
3.19 
(0.99) 
Time: F(1,14)=2.92, p=0.110, η)
&=0.04 
Group: F(1,14)=1.30, p=0.273, η)
&=0.07 
Group x Time: F(1,14)=0.48, p=0.499, η)
&=0.01 
Lymphocytes 
(103/mm3) 
2.30  
(0.57) 
1.93*  
(0.45) 
1.85 
(0.56) 
1.74 
(0.33) 
Time: F(1,14)=4.06, p=0.064, η)
&=0.057 
Group: F(1,14)=1.94, p=0.185, η)
&=0.10 
Group x Time: F(1,14)=1.16, p=0.301, η)
&=0.02 
Monocytes 
(103/mm3) 
0.38  
(0.15) 
0.34 
(0.09) 
0.38 
(0.10) 
0.39 
(0.11) 
Time: F(1,14)=0.12, p=0.736, η)
&=0.01 
Group: F(1,14)=0.26, p=0.619, η)
&=0.01 
Group x Time: F(1,14)=0.41, p=0.533, η)
&=0.01 
Eosinophil 
(103/mm3) 
0.16  
(0.07) 
0.16 
(0.07) 
0.15 
(0.10) 
0.19 
(0.09) 
Time: F(1,14)=1.02, p=0.329, η)
&=0.01 
Group: F(1,14)=0.07, p=0.790, η)
&=0.01 
Time: F(1,14)=0.82, p=0.379, η)
&=0.01 
Basophils 
(103/mm3) 
0.03  
(0.01) 
0.03 
(0.01) 
0.03 
(0.01) 
0.03 
(0.02) 
Time: F(1,14)=0.18, p=0.675, η)
&=0.01 
Group: F(1,14)=0.07, p=0.800, η)
&=0.01 
Group x Time: F(1,14)=0, p=0.990, η)
&=0.01 
Neutrophils:Lymph
ocytes  
ratio 
1.13  
(0.46) 
1.55 t 
(0.45) 
1.81 
(0.80) 
1.94 
(0.75) 
Time: F(1,14)=3.91, p=0.068, η)
&=0.04 
Group: F(1,14)=2.92, p=0.110, η)
&=0.15 
Group x Time: F(1,14)=1.07, p=0.318, η)
&=0.01 
Note: Pre and post intervention values are presented as mean (standard deviation) 
Pairwise comparisons: *p<0.05 respect to pre intervention values, t p=0.051 respect to 
baseline values. 
